Join
Live feed
·
INSIDERFilingvia Quantisnow
Esperion Therapeutics Inc. logo

Chief Commercial Officer Harlow John B. Jr. returned 424,536 shares to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ESPR (Esperion Therapeutics Inc.) and more on Quantisnow.